Inhalable Insulin Delayed, Produces More Antibodies

| Sep 1, 2001

Exubera, an inhalable insulin being developed by Inhale Theraputics of San Carlos, California, and Pfizer, might have to wait a little while longer until it ‘breathes' life into the diabetes market.

On July 18, the San Francisco Chronicle reported that Pfizer announced in an earnings statement that the U.S. Food and Drug Administration would probably want more safety data about possible side effects that have surfaced during clinical trials. According to the Chronicle article, last month Pfizer and Inhale revealed that patients who took a combination of injected and inhaled insulin produced more antibodies to the drug than patients who only injected insulin.

Exubera, a dry insulin powder that is inhaled into the lungs using a special device, was originally expected to submitted to the FDA for marketing approval by the end of this year. Diabetes Health reported in its July issue that in clinical trials, one out of 1,000 patients that used Exubera developed lung damage.

Aradigm Corporation of Hayward, California, and Novo Nordisk are also developing an inhalable insulin called the AERx insulin delivery system.

Click Here To View Or Post Comments

Categories: Diabetes, Diabetes, Food, Insulin, Novo Nordisk

Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12th Annual Product Reference Guide
  • Insulin Syringe Chart
  • Insulin Pen Needles Chart
  • Fast-Acting Glucose
  • Sharps Disposal
  • Blood Glucose Meters Chart
  • Insulin Pumps Chart
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Top Rated
Print | Email | Share | Comments (0)

You May Also Be Interested In...


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...

Username: Password:
©1991-2015 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.